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Process Map (Figure 1)

Background
In 2017, an estimated 21 million US adults, equivalent to 1 in 13 people,
had a substance use disorder.1 In 2015, New Mexico had the 8th highest
overdose death rate in the nation with the highest number of overall
deaths occurring in Bernalillo County .2 Screening at the time of
presentation to the hospital can provide an important opportunity to offer
resources and direct care appropriately. At the time of this study,
University of New Mexico Hospital did not have a tool to identify patients
with substance use disorders (SUD) as part of intake protocols. Similar
studies conducted previously found that factors important to successful
implementation include: comprehensive education and training, intra and
inter-organization communication and collaboration, host site and
practitioner support, and champions to lead and direct management of the
program.3,4

Project Description
A nursing survey to assess buy-in and potential barriers to successful SUD
implementation was completed to inform how a screening protocol could be
most effectively incorporated into workflow. Subsequently, a patient SUD
screening pilot was launched on 4 West, the largest UNMH inpatient adult
medical-surgical unit, over a 14-day period in 2019. The Drug Abuse
Screening Tool 10 question or DAST-10 (Table 2), an evidence-based,
sensitive, and specific tool for identification of substance use, was selected
for implementation. 5 All patients admitted to the unit over the course of the
pilot were screened for eligibility. The screening was then administered to
those eligible and willing (Figure 1).
Exclusion criteria included non-English speaking, encephalopathic or if
otherwise deemed inappropriate for screening by the surveyor (e.g.
clinically inappropriate).
Patients with a positive screen were assessed for interest in treatment and
offered a compilation of local resources for support.

Results
Screening Outcomes (Table 1)
Outcome
Patient Eligible for Screening (n=67)
Patient Ineligible for Screening: Non-English Speaking (n=33)
Patient Ineligible for Screening: Encephalopathic (n=33)
Patient Ineligible for Screening: Not appropriate for screening per surveyor (n=33)
Patient Ineligible for Screening: Other (n=33)
Patient Declines Screening (n=33)
Negative Screen (n=22)
Positive Screen (n=22)
If Positive Screen, Resources Desired? (n=3)
DAST-10 Screening Questionnaire (Table 2)
These questions refer to the past 12 months
1. Have you used drugs other than those required for
medical reasons?
2. Do you abuse more than one drug at a time?
3. Are you always able to stop using drugs when you want
to? (If never use drugs, answer “Yes”)

No Yes
0
1
0
1

1
0

4. Have you had “blackouts” or “flashbacks” as a result of
drug use?
5. Do you ever feel bad or guilty about your drug use? If
never use drugs, choose “No”

0

1

0

1

6. Does your spouse (or parents) ever complain about your
involvement with drugs?

0

7. Have you neglected your family because of your use of
drugs?
8. Have you engaged in illegal activities in order to obtain
drugs?
9. Have you ever experienced withdrawal symptoms (felt
sick) when you stopped taking drugs?

0

1

0

1

0

1

10. Have you had medical problems as a result of your
drug use (e.g., memory loss, hepatitis, convulsions,
bleeding, etc.?)

0

Count
49% (34)
21% (7)
15% (5)
27% (9)
36% (12)
36% (12)
86% (19)
14% (3)
33% (1)

SUD Screening Patient Eligibility and Participation
(Figure 2)
(n=67)
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A total of 67 patients admitted to the unit were reviewed. Of the 67
patients, 33 patients (49.2%) were eligible for screening (Figure 2).
Primary reasons for ineligibility included: inappropriate for screening
based on surveyor judgment (27.3%), non-English speaking (21.2%), and
patient was encephalopathic (15.2%). In total, 22 patients agreed to
participate in the survey and 11 patients declined. Of the 22 participants,
3 (13.6%) screened positive on the DAST-10. Of those who screened
positive for substance use, one patient was interested in receiving
resources (Table 2).

Conclusion
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Surveyed nurses (n=19) indicated strong buy-in for SUD screening with
94% of those surveyed indicating that they agreed or strongly agreed that
SUD screening was important. Barriers to implementation identified
included: patient fear admitting drug use for legal/ social reasons, time
required to complete screening and fitting it into workflow, and acuity of
illness or cognitive barriers that would preclude screening.
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In this proof-of-concept pilot, performance of the DAST-10 survey led to
the identification of 14% of hospitalized patients on 4 West with a SUD.
Beyond the ability of the screen to identify a number of patients with SUD,
performance of the survey was able to be tied to treatment linkage.
Key identified barriers to implementation included staff time to complete
screening, patient willingness/comfort to answer screening questions, and
a significant number of patients who were not able to answer screening
questions due to language barriers or acute illness and encephalopathy.
Future directions for this project include creating an EMR based version of
the screen included in the admission workflow for all inpatient units and
the ED, a Spanish Language version, an automatic referral to a future
substance use consult service for all positive screens as well as reminders
to complete the screen prior to discharge.

